Education Webinars
Persistent Spike Protein in Immune Cells Up to 245 Days After Vaccination – New Study Explained
A newly published, peer-reviewed study in Taylor & Francis Online reveals the detection of spike protein (S1 subunit) in CD16+ monocytes up to 245 days post COVID-19 vaccination in individuals with post-COVID-19 vaccine syndrome (PCVS).
In this lecture, Dr. Mobeen Syed explains:
- The study findings and methodology
- Spike protein persistence in immune cells
- Correlation between symptoms and immune biomarkers
- The role of monocyte subtypes in inflammation
- Potential mechanisms involving fractalkine, CCR5, sCD40L, VEGF, and TNF-alpha
- Why inflammation may persist — and how it might be targeted
This talk is designed for clinicians, medical students, and researchers seeking to understand the immunological patterns seen in PCVS and Long COVID-like presentations.
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.